179 related articles for article (PubMed ID: 30093619)
1. Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1.
Xu X; Li Y; Bharath SR; Ozturk MB; Bowler MW; Loo BZL; Tergaonkar V; Song H
Nat Commun; 2018 Aug; 9(1):3183. PubMed ID: 30093619
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.
Li Y; Zhou QL; Sun W; Chandrasekharan P; Cheng HS; Ying Z; Lakshmanan M; Raju A; Tenen DG; Cheng SY; Chuang KH; Li J; Prabhakar S; Li M; Tergaonkar V
Nat Cell Biol; 2015 Oct; 17(10):1327-38. PubMed ID: 26389665
[TBL] [Abstract][Full Text] [Related]
3. NF-κB/p52 augments ETS1 binding genome-wide to promote glioma progression.
Sim N; Li Y
Commun Biol; 2023 Apr; 6(1):445. PubMed ID: 37087499
[TBL] [Abstract][Full Text] [Related]
4. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of Ets1 cooperative binding to widely separated sites on promoter DNA.
Babayeva ND; Baranovskaya OI; Tahirov TH
PLoS One; 2012; 7(3):e33698. PubMed ID: 22432043
[TBL] [Abstract][Full Text] [Related]
6. DNA specificity determinants associate with distinct transcription factor functions.
Hollenhorst PC; Chandler KJ; Poulsen RL; Johnson WE; Speck NA; Graves BJ
PLoS Genet; 2009 Dec; 5(12):e1000778. PubMed ID: 20019798
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
Vallarelli AF; Rachakonda PS; André J; Heidenreich B; Riffaud L; Bensussan A; Kumar R; Dumaz N
Oncotarget; 2016 Aug; 7(33):53127-53136. PubMed ID: 27449293
[TBL] [Abstract][Full Text] [Related]
8. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.
Vaughan CA; Deb SP; Deb S; Windle B
Oncotarget; 2014 Jan; 5(2):417-27. PubMed ID: 24481480
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of Ets1 activation by Runx1.
Shrivastava T; Mino K; Babayeva ND; Baranovskaya OI; Rizzino A; Tahirov TH
Leukemia; 2014 Oct; 28(10):2040-8. PubMed ID: 24646888
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA.
Babayeva ND; Wilder PJ; Shiina M; Mino K; Desler M; Ogata K; Rizzino A; Tahirov TH
Cell Cycle; 2010 Aug; 9(15):3054-62. PubMed ID: 20686355
[TBL] [Abstract][Full Text] [Related]
11. Structures of NF-κB p52 homodimer-DNA complexes rationalize binding mechanisms and transcription activation.
Pan W; Meshcheryakov VA; Li T; Wang Y; Ghosh G; Wang VY
Elife; 2023 Feb; 12():. PubMed ID: 36779700
[TBL] [Abstract][Full Text] [Related]
12. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
13. A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1.
Samorodnitsky D; Szyjka C; Koudelka GB
J Biol Chem; 2015 Sep; 290(36):22101-10. PubMed ID: 26195629
[TBL] [Abstract][Full Text] [Related]
14. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B regulates transcription of the mouse telomerase catalytic subunit.
Yin L; Hubbard AK; Giardina C
J Biol Chem; 2000 Nov; 275(47):36671-5. PubMed ID: 10970902
[TBL] [Abstract][Full Text] [Related]
17. NFκB drives TERT promoter reactivation in cancer.
Tergaonkar V
Cell Cycle; 2016; 15(2):156-7. PubMed ID: 26588470
[No Abstract] [Full Text] [Related]
18. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Bell RJ; Rube HT; Kreig A; Mancini A; Fouse SD; Nagarajan RP; Choi S; Hong C; He D; Pekmezci M; Wiencke JK; Wrensch MR; Chang SM; Walsh KM; Myong S; Song JS; Costello JF
Science; 2015 May; 348(6238):1036-9. PubMed ID: 25977370
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
Murakami T; Hirai H; Suzuki T; Fujisawa J; Yoshida M
Virology; 1995 Feb; 206(2):1066-74. PubMed ID: 7856081
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Yuan X; Dai M; Xu D
Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
